Weiss Multi Strategy Advisers LLC Agios Pharmaceuticals, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $1.17 Million - $1.59 Million	-16,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $239,320 - $346,120	4,000 Added 33.33%	16,000 $1.31 Million
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $104,240 - $144,660	2,000 Added 20.0%	12,000 $686,000
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $548,900 - $671,200	10,000	10,000 $668,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.